A 65‐year‐old Asian, nonsmoking female was initially diagnosed with EGFR‐mutant (exon 21 L858R) NSCLC and multiple BM (adenocarcinoma; T2aN0M1c, stage IVb) in June 2018. This evidence concerns the gene EGFR and non-small cell lung carcinoma.